Pre-Made Efgartigimod Alfa Biosimilar, Recombinant Protein targeting FCGRT: Recombinant therapeutic protein targeting FCRN/FcgammaRn/alpha-chain for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-814

Pre-Made Efgartigimod Alfa Biosimilar, Recombinant Protein targeting FCGRT: Recombinant therapeutic protein targeting FCRN/FcgammaRn/alpha-chain is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Efgartigimod is a mutated human immunoglobulin G1 Fc fragment. Efgartigimod alfa is a human IgG1 antibody fragment that binds to FcRn, thus preventing IgG recycling and subsequently reducing the amount of circulating IgG, including the autoantibodies responsible for myasthenia gravis.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-814-1mg 1mg 3090
GMP-Bios-INN-814-10mg 10mg Inquiry
GMP-Bios-INN-814-100mg 100mg Inquiry
GMP-Bios-INN-814-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Efgartigimod Alfa Biosimilar, Recombinant Protein targeting FCGRT: Recombinant therapeutic protein targeting FCRN/FcgammaRn/alpha-chain
INN Name Efgartigimod Alfa
TargetFCGRT
FormatRecombinant Protein
Derivationhuman
Species Reactivityhuman
CH1 IsotypeFc - gamma1
VD LCFc - gamma1
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesarGEN-X (Brenda Netherlands)
Conditions Approved
Conditions Active
Conditions Discontinued
Development TechABDEG™